Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» IPOs
IPOs
Cue Health, Google's COVID-19 test provider, raises $200M in an IPO
Medtech Dive
Mon, 09/27/21 - 10:56 am
Cue Health
Google
IPOs
diagnostics
Bankrolled by Pfizer and Bayer, Pyxis files for $100M IPO to take cancer drugs into the clinic
Fierce Pharma
Mon, 09/20/21 - 11:17 am
Pyxis Oncology
IPOs
Pfizer
Bayer
Three more biotechs hit Nasdaq as the sector, now with more than $13B raised, continues barreling toward record
Endpoints
Wed, 09/15/21 - 10:56 am
IPOs
SPACs
NASDAQ
Pasithea Therapeutics
Tyra Biosciences
DiCE Therapeutics
Five Life Sciences Companies Ramping up the Fall Flood of IPOs
BioSpace
Mon, 09/13/21 - 11:28 pm
IPOs
Exscientia
Sumitomo Dainippon Pharma
Cingluate
Tyra Biosciences
Procept BioRobotics
IPO filings are back on the biotech menu as an ADHD drug developer submits its Nasdaq paperwork
Endpoints
Fri, 09/10/21 - 11:12 am
IPOs
ADHD
Cingulate
After pandemic delay and a South Korean deal, Boston-area biotech raises Series B with sights on IPO
Endpoints
Thu, 08/26/21 - 10:59 am
Neurogastrx
IPOs
South Korea
Tyra Biosciences wants to bank $100M for an IPO
Fierce Biotech
Mon, 08/23/21 - 11:02 am
Tyra Biosciences
IPOs
Dermata Therapeutics prices ~$18M IPO
Seeking Alpha
Fri, 08/13/21 - 12:05 pm
Dermata Therapeutics
dermatology
IPOs
Virtually unknown mRNA upstart rides SPAC to Nasdaq with a $1.5B valuation as RA-backed neuro player prices IPO
Endpoints
Tue, 08/10/21 - 10:38 am
GreenLight Biosciences
SPAC
IPOs
MRNA
Bayer bets $1.5B that Vividion will help it target the 'undruggable' and make 1+1=3
Fierce Biotech
Thu, 08/5/21 - 11:11 am
Bayer
Vividion
M&A
IPOs
R&D
Icosavax’s $182M IPO haul is key for RSV, but eyes are on its Covid vaccine too
MedCity News
Sun, 08/1/21 - 11:53 pm
IPOs
Icosavax
RSV
vaccines
Six more biotechs price public debuts just before the start of the weekend
Endpoints
Fri, 07/30/21 - 12:15 pm
IPOs
Tenaya Therapeutics
Immuneering
Rani Therapeutics
IN8Bio
Omega Therapeutics
MaxCyte
Three Biopharma Companies Made Public Debut on Nasdaq Exchange
BioSpace
Thu, 07/29/21 - 10:59 pm
IPOs
Nuvalent
Rallybio
Icosavax
NASDAQ
Caribou raises $304M in one of gene editing's most lucrative IPOs
BioPharma Dive
Sat, 07/24/21 - 06:34 pm
Caribou Biosciences
CRISPR
gene editing
IPOs
IPOs continue to bustle as three more biotechs prepare to make the Nasdaq leap
Endpoints
Mon, 07/19/21 - 11:13 pm
IPOs
Adagio Therapeutics
Castle Creek Biosciences
Eliem Therapeutics
COVID-19 drug developer Adagio plans IPO to cap fast rise
BioPharma Dive
Mon, 07/19/21 - 10:57 am
Adagio Therapeutics
IPOs
antibodies
COVID-19
Erasca’s IPO leads the way as three cancer biotechs raise $534M for clinical trials
MedCity News
Sun, 07/18/21 - 09:49 pm
Erasca
IPOs
clinical trials
Imago BioSciences
TScan Therapeutics
Nuvalent joins the IPO party less than 6 months after launch, while Icosavax kicks its 'soccer ball' VLPs to Nasdaq
Endpoints
Wed, 07/7/21 - 11:07 am
Nuvalent
IPOs
Icosavax
VLP platform
All in on amyloid, Acumen Pharma’s IPO raises $160M for Alzheimer’s drug R&D
MedCity News
Fri, 07/2/21 - 10:54 am
Acumen Pharmaceuticals
IPOs
Alzheimer's disease
Biotech listings shows few signs of cooling
EP Vantage
Fri, 07/2/21 - 10:53 am
biotech
IPOs
Lyell Immunopharma
Recursion Pharmaceuticals
Centessa Pharmaceuticals
Verve Therapeutics
Graphite Bio
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »